Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - TOTAL CURRENT LIABILITIES
Total Current Liabilities PRPH - ProPhase Labs, Inc.
20.9 M
LAST VALUE
15.91%
2 YEAR CAGR
37.57%
5 YEAR CAGR
16.26%
10 YEAR CAGR